Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals, Inc.verified




Market Cap:


Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis. It is also developing AMX0035 for other neurodegenerative diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.[Read more]



IPO Date


Stock Exchange




The Current Ratio as of June 2024 (TTM) for Amylyx Pharmaceuticals, Inc. (AMLX) is 4.48

According to Amylyx Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.48. This represents a change of -31.94% compared to the average of 6.58 of the last 4 quarters.

Amylyx Pharmaceuticals, Inc. (AMLX) Historical Current Ratio (quarterly & annually)

How has AMLX Current Ratio performed in the past?

The mean historical Current Ratio of Amylyx Pharmaceuticals, Inc. over the last ten years is 4.45. The current 4.48 Current Ratio has changed 9.96% with respect to the historical average. Over the past ten years (40 quarters), AMLX's Current Ratio was at its highest in in the March 2022 quarter at 9.58. The Current Ratio was at its lowest in in the March 2021 quarter at 0.

Quarterly (TTM)









Amylyx Pharmaceuticals, Inc. (AMLX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Amylyx Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 213.43%

Maximum Annual Current Ratio = 8.20

Minimum Annual Increase = -30.92%

Minimum Annual Current Ratio = 0.71

Quarterly (TTM)
YearCurrent RatioChange

Amylyx Pharmaceuticals, Inc. (AMLX) Average Current Ratio

How has AMLX Current Ratio performed in the past?

The current Current Ratio of Amylyx Pharmaceuticals, Inc. (AMLX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg


5-year avg


10-year avg


Amylyx Pharmaceuticals, Inc. (AMLX) Current Ratio vs. Peers

How is AMLX’s Current Ratio compared to its peers?

Amylyx Pharmaceuticals, Inc.’s Current Ratio is less than Terns Pharmaceuticals, Inc. (27.85), less than Acumen Pharmaceuticals, Inc. (30.20), less than Inozyme Pharma, Inc. (14.05), greater than X4 Pharmaceuticals, Inc. (3.71), less than Day One Biopharmaceuticals, Inc. (10.93), less than Mereo BioPharma Group plc (4.86), less than PDS Biotechnology Corporation (4.56), less than HOOKIPA Pharma Inc. (4.50),

Build a custom stock screener for Amylyx Pharmaceuticals, Inc. (AMLX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amylyx Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Amylyx Pharmaceuticals, Inc. (AMLX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Amylyx Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Amylyx Pharmaceuticals, Inc.'s Current Ratio?

How is the Current Ratio calculated for Amylyx Pharmaceuticals, Inc. (AMLX)?

What is the highest Current Ratio for Amylyx Pharmaceuticals, Inc. (AMLX)?

What is the 3-year average Current Ratio for Amylyx Pharmaceuticals, Inc. (AMLX)?

What is the 5-year average Current Ratio for Amylyx Pharmaceuticals, Inc. (AMLX)?

How does the current Current Ratio for Amylyx Pharmaceuticals, Inc. (AMLX) compare to its historical average?